Knight Therapeutics (KHTRF) 6.4000 $KHTRF Knight and

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Knight Therapeutics (KHTRF) 6.4000 $KHTRF

Knight and Ember Expand Distribution Partnership
GlobeNewswire - Wed Jul 06, 7:08AM CDT
Knight Therapeutics Inc. (TSX:GUD) ("Knight", a leading Canadian specialty pharmaceutical company, and Ember Therapeutics, Inc. (OTCQB:EMBT) ("Ember", a New York-based biotech company developing targeted therapies for osteoarthritis, kidney fibrosis, and other regenerative medicines, today announced an expansion of their exclusive distribution agreement signed in August 2015. Pursuant to the amendment, Knight's territorial rights to Ember's Bone Morphogenetic Protein-7 ("BMP-7" pipeline, which originally included Canada, Israel, Russia and sub-Saharan Africa, have been expanded to include Romania and the Caribbean. Additionally, Knight has acquired the exclusive distribution rights for two diversified products recently acquired by Ember: Migralex(TM), a commercially-available over-the-counter medication for treating pain, and ICX-RHY/Vavelta(R), a development stage regenerative medicine asset, in all of the above-mentioned territories.
GUD.TO: 8.46 (+0.02)

Knight Therapeutics Inc. Announces Election of Directors
Marketwire Canada - Thu Jun 16, 5:01PM CDT
MONTREAL, QUEBEC--(Marketwired - Jun 16, 2016) - Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Company" announced today that each director nominee listed in the Management Information Circular dated May 13, 2016 was elected as Director of the Company during the Annual Meeting of the Shareholders held in Montréal, Québec.
GUD.TO: 8.46 (+0.02)

Long Zone Holdings Announces Acquisition of Knight Therapeutics Inc. Common Shares
Marketwired - Thu Jun 02, 5:31PM CDT
MONTREAL, QUEBEC--(Marketwired - Jun 2, 2016) - Long Zone Holdings Inc. ("the Corporation" announced that pursuant to a previously announced prospectus offering ("the Offering" by Knight Therapeutics Inc. ("Knight", it has today acquired ownership of 45,000 common shares of Knight ("the Acquired Shares" representing approximately 0.03% of the outstanding common shares of Knight. The Acquired Shares were acquired at a price of $8.00 per common share for an aggregate consideration of $360,000.

Knight to Present at Both the National Bank Financial Quebec Conference in Montreal and the Jefferies Healthcare Conference in New York City
Marketwired - Tue May 31, 7:01AM CDT
MONTREAL, QUEBEC--(Marketwired - May 31, 2016) - Knight Therapeutics Inc. (TSX:GUD) ("Knight", a leading Canadian specialty pharmaceutical company, announced today that Jonathan Ross Goodman, President and CEO, is scheduled to present at the National Bank Financial Quebec Conference on Wednesday, June 1, 2016 at 2:00 pm ET at the Hotel Le Crystal in Montreal, while Jeffrey Kadanoff, CFO, is scheduled to present a corporate update at the Jefferies Healthcare Conference on Thursday, June 9, 2016 at 9:30 am ET at the Grand Hyatt New York. A copy of the Jefferies Healthcare Conference presentation will be available at www.gud-knight.com.
GUD.TO: 8.46 (+0.02)

Knight Reports First Quarter 2016 Results
Marketwire Canada - Tue May 10, 5:01AM CDT
MONTREAL, CANADA--(Marketwired - May 10, 2016) - Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Company", a leading Canadian specialty pharmaceutical company, today reported financial results for its first quarter ended March 31, 2016. In thousands of Canadian dollars except for share and per share amounts.
GUD.TO: 8.46 (+0.02)

Knight Finds EMPAthetic Partner for Neuragen(R) in the Middle East
Marketwired - Mon Apr 25, 7:02AM CDT
Knight Therapeutics Inc. (TSX: GUD), through one of its wholly-owned subsidiaries ("Knight", announced today that it has entered into an exclusive distribution agreement with EMPA Healthcare LLC ("EMPA" to commercialize Neuragen(R), a topical natural health product used to relieve the symptoms of peripheral nerve pain, in the United Arab Emirates and Kuwait. EMPA will also have non-exclusive distribution rights in the other Gulf Cooperation Council ("GCC" countries. Knight may extend exclusivity on a country-by-country basis should certain minimum sales targets be met in each GCC country. Knight sold the rights to Neuragen(R) in the U.S. in June 2015 and retains the rights for all other territories.
GUD.TO: 8.46 (+0.02)

Knight Receives NOD from Health Canada for ATryn(R)
Marketwired - Mon Apr 25, 7:02AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight", a leading Canadian specialty pharmaceutical company, today announced that it has received a Notice of Deficiency ("NOD" for its ATryn(R) New Drug Submission.
GUD.TO: 8.46 (+0.02)

Knight Blooms at Healthcare Investor Conference in Toronto
Marketwired - Mon Apr 25, 7:02AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight", a leading Canadian specialty pharmaceutical company, announced today that Mr. Jonathan Ross Goodman, President and CEO, and Mr. Jeffrey Kadanoff, CFO, are scheduled to present a corporate update at the Bloom Burton & Co. Healthcare Investor Conference on Monday, May 2, 2016 at 1:30 pm ET at the Sheraton Centre Toronto Hotel. A copy of the presentation will be available at www.gud-knight.com.
GUD.TO: 8.46 (+0.02)

Knight Therapeutics CFO Jeffrey Kadanoff at Cercle Finance et Placement du Québec on April 19
CNW Group - Wed Apr 13, 9:30AM CDT
Members of the media are invited to a presentation by Jeffrey Kadanoff, Chief Financial Officer of Knight Therapeutics, who will be the guest speaker at Le Cercle finance et placement du Québec's next luncheon conference, to be held on Tuesday, April 19. Please note that the presentation will be in French.

Knight Reports Fourth Quarter and Year-Ended December 31, 2015 Results
Marketwired - Thu Mar 24, 5:01AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Company", a leading Canadian specialty pharmaceutical company, today reported financial results for its fourth quarter and year-ended December 31, 2015.
GUD.TO: 8.46 (+0.02)

Knight Receives Dividend From Medison
Marketwired - Wed Mar 23, 7:02AM CDT
Knight Therapeutics Inc. (TSX: GUD), through one of its wholly-owned subsidiaries ("Knight", announced today receipt of a NIS 7.1 million ($2.4 million) dividend from Medison Biotech (1995) Ltd. ("Medison". Knight owns 28.3% of Medison, Israels 4th largest specialty pharma company ranked by revenue.
GUD.TO: 8.46 (+0.02)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 225

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 354

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 527

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 631

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 468

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 479

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 298

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 391

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 446

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring AI's Transformative Impact on Global Filmmaking

Updated Category News Views 171

The Future of Filmmaking in the Age of AI The Short Shorts Film Festival & Asia (SSFF & ASIA) recently hosted an engaging conference focused on how artificial intelligence is revolutionizing the filmmaking process. This Academy Award–qualifying festival has become a significant platform for showcasing short films from around the globe. During the event, titled 'The...

Continue Reading
Darkex Launches Revolutionary Crypto Trading Platform Today

Updated Category News Views 365

The Launch of the Darkex Cryptocurrency Trading Platform The long-awaited cryptocurrency exchange, Darkex, has officially launched, promising a top-notch trading experience for both retail and institutional investors. With a strong focus on security, innovation, and user-friendly services, Darkex aims to reshape the cryptocurrency trading landscape. Setting a New...

Continue Reading
Understanding the Saver's Credit: A Key to Retirement Savings

Updated Category News Views 187

The Importance of the Saver's Credit for Retirement Savers The Saver's Credit is a valuable resource for many individuals aiming to bolster their retirement savings while easing their tax burdens. Recent findings reveal that over half of U.S. workers remain unaware of this advantageous tax credit designed to aid retirement savers. Understanding this credit can empower...

Continue Reading
Why Stock Splits Matter: Insights on Major Tech Players

Updated Category News Views 190

Stock splits became a hot topic in the investment world during 2024, with companies like Nvidia and Sony Group making headlines. Traders were on high alert as these maneuvers shifted market dynamics. A stock split isn’t just a cosmetic change; it’s a tactical play that can signal confidence from management, but does it really move the needle for investors? Let’s...

Continue Reading
Accelerating Growth in Global Dry Film Photoresist Market

Updated Category News Views 177

Global Dry Film Photoresist Market Overview The dry film photoresist market is primed for substantial growth as it experiences increased demand across various industries. This market is characterized by its segmentation into types, namely positive and negative dry film photoresists, and applications including PCB manufacturing and semiconductor packaging. Projections...

Continue Reading